Publications

  1. Bingener J, Loomis EA, Gostout CJ, Zielinski MD, Buttar NS, Wong Kee Song LM, Baron TH, Ghahfarokhi LS, Rajan E. Feasibility of NOTES omental plug repair of perforated peptic ulcers: results from a clinical pilot trial. Surg Endosc. 2013 Jun; 27(6):2201-8. Epub 2013 Jan 26. 2299529
    View PubMed
  2. Bick BL, Song LM, Buttar NS, Baron TH, Nichols FC, Maldonado F, Katzka DA, Enders FT, Topazian MD. Stent-associated esophagorespiratory fistulas: incidence and risk factors. Gastrointest Endosc. 2013 Feb; 77(2):181-9. Epub 2012 Dec 11. 2305445
    View PubMed
  3. Bansal A, Lee IH, Hong X, Mathur SC, Tawfik O, Rastogi A, Buttar N, Visvanathan M, Sharma P, Christenson LK. Discovery and validation of Barrett's esophagus microRNA transcriptome by next generation sequencing. PLoS One. 2013; 8(1):e54240. Epub 2013 Jan 23. 2303841
    View PubMed
  4. Samadder NJ, Bonin EA, Buttar NS, Baron TH, Gostout CJ, Topazian MD, Song LM. Placement of a covered stent for palliation of a cavitated colon cancer by using a novel over-the-scope technique (with video). Gastrointest Endosc. 2012 Dec; 76(6):1275-7. Epub 2012 Mar 7. 2326507
    View PubMed
  5. Rao AS, Misra S, Buttar NS, Baron TH, Wong Kee Song LM. Combined endoscopic-interventional radiologic approach for the treatment of bleeding gastric varices in the setting of a large splenorenal shunt. Gastrointest Endosc. 2012 Nov; 76(5):1064-5. Epub 2012 Jan 20. 2219693
    View PubMed
  6. Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE, Chak A, Devault KR, Weinberg DS, Della'Zanna G, Richmond E, Smyrk TC, Mandrekar SJ, Limburg PJ, Cancer A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology. 2012 Oct; 143(4):917-26.e1. Epub 2012 Jul 11. 2277577
    View PubMed
  7. Nelsen EM, Kirihara Y, Takahashi N, Shi Q, Lewis JT, Namasivayam V, Buttar NS, Dunagan KT, Prasad GA. Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):728-34; quiz e61-2. Epub 2012 Mar 17. 2235292
    View PubMed
  8. Wang KK, Tian JM, Gorospe E, Penfield J, Prasad G, Goddard T, Wongkeesong M, Buttar NS, Lutzke L, Krishnadath S. Medical and endoscopic management of high-grade dysplasia in Barrett's esophagus. Dis Esophagus. 2012 May; 25(4):349-55. Epub 2012 Mar 12. 2235313
    View PubMed
  9. Seo S, Lomberk G, Mathison A, Buttar N, Podratz J, Calvo E, Iovanna J, Brimijoin S, Windebank A, Urrutia R. Kruppel-like factor 11 differentially couples to histone acetyltransferase and histone methyltransferase chromatin remodeling pathways to transcriptionally regulate dopamine D2 receptor in neuronal cells. J Biol Chem. 2012 Apr 13; 287(16):12723-35. Epub 2012 Feb 28. 2242398
    View PubMed
  10. Lomberk G, Mathison AJ, Grzenda A, Seo S, DeMars CJ, Rizvi S, Bonilla-Velez J, Calvo E, Fernandez-Zapico ME, Iovanna J, Buttar NS, Urrutia R. Sequence-specific recruitment of heterochromatin protein 1 via interaction with Kruppel-like factor 11, a human transcription factor involved in tumor suppression and metabolic diseases. J Biol Chem. 2012 Apr 13; 287(16):13026-39. Epub 2012 Feb 08. 2222914
    View PubMed
  11. Wang Y, Ding Q, Yen CJ, Xia W, Izzo JG, Lang JY, Li CW, Hsu JL, Miller SA, Wang X, Lee DF, Hsu JM, Huo L, Labaff AM, Liu D, Huang TH, Lai CC, Tsai FJ, Chang WC, Chen CH, Wu TT, Buttar NS, Wang KK, Wu Y, Wang H, Ajani J, Hung MC. The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell. 2012 Mar 20; 21(3):374-87. 2238274
    View PubMed
  12. Daftary GS, Lomberk GA, Buttar NS, Allen TW, Grzenda A, Zhang J, Zheng Y, Mathison AJ, Gada RP, Calvo E, Iovanna JL, Billadeau DD, Prendergast FG, Urrutia R. Detailed structural-functional analysis of the Kruppel-like factor 16 (KLF16) transcription factor reveals novel mechanisms for silencing Sp/KLF sites involved in metabolism and endocrinology. J Biol Chem. 2012 Mar 2; 287(10):7010-25. Epub 2011 Dec 27. 2238964
    View PubMed
  13. Bonnefond A, Lomberk G, Buttar N, Busiah K, Vaillant E, Lobbens S, Yengo L, Dechaume A, Mignot B, Simon A, Scharfmann R, Neve B, Tanyolac S, Hodoglugil U, Pattou F, Cave H, Iovanna J, Stein R, Polak M, Vaxillaire M, Froguel P, Urrutia R. Disruption of a novel Kruppel-like transcription factor p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS mutation found in neonatal diabetes mellitus. J Biol Chem. 2011 Aug 12; 286(32):28414-24. Epub 2011 May 18. 2188034
    View PubMed
  14. Bonnefond A, Lomberk G, Buttar N, Busiah K, Vaillant E, Lobbens S, Yengo L, Dechaume A, Mignot B, Simon A, Scharfmann R, Neve B, Tanyolac S, Hodoglugil U, Pattou F, Cave H, Iovanna J, Stein R, Polak M, Vaxillaire M, Froguel P, Urrutia R. Disruption of a novel KLF-p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS mutation found in neonatal diabetes mellitus J Biol Chem [Epub ahead of print]. 2011 May 18. 2170120
  15. Fernandez-Zapico ME, Lomberk GA, Tsuji S, DeMars CJ, Bardsley MR, Lin YH, Almada LL, Han JJ, Mukhopadhyay D, Ordog T, Buttar NS, Urrutia R. A functional family-wide screening of SP/KLF proteins identifies a subset of suppressors of KRAS-mediated cell growth. Biochem J. 2011 Apr 15; 435(2):529-37. 2144645
    View PubMed
  16. Wang KK, Okoro N, Prasad G, WongKeeSong M, Buttar NS, Tian J. Endoscopic evaluation and advanced imaging of Barrett's esophagus. Gastrointest Endosc Clin N Am. 2011 Jan; 21(1):39-51. 2125572
    View PubMed
  17. Rizvi S, Demars CJ, Comba A, Gainullin VG, Rizvi Z, Almada LL, Wang K, Lomberk G, Fernandez-Zapico ME, Buttar NS. Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis. Cancer Res. 2010 Sep 1; 70(17):6787-96. Epub 2010 Jul 20. 2110389
    View PubMed
  18. Buttar NS, DeMars CJ, Lomberk G, Rizvi S, Bonilla-Velez J, Achra S, Rashtak S, Wang KK, Fernandez-Zapico ME, Urrutia R. Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis. J Biol Chem. 2010 Apr 9; 285(15):11433-44. Epub 2010 Feb 12. 1986028
    View PubMed
  19. Badreddine RJ, Prasad GA, Wang KK, Song LM, Buttar NS, Dunagan KT, Lutzke LS, Borkenhagen LS. Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus. Gastrointest Endosc. 2010 Apr; 71(4):697-703. Epub 2009 Dec 03. 1995695
    View PubMed
  20. Singh A, Demars C, Buttar NS. Molecular determinants of metaplastic and neoplastic transformation in the esophageal epithelium. Prog Mol Biol Transl Sci. 2010; 96:63-92. 2136268
    View PubMed
  21. Kim SM, Park YY, Park ES, Cho JY, Izzo JG, Zhang D, Kim SB, Lee JH, Bhutani MS, Swisher SG, Wu X, Coombes KR, Maru D, Wang KK, Buttar NS, Ajani JA, Lee JS. Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS One. 2010; 5(11):e15074. Epub 2010 Nov 30. 2136362
    View PubMed
  22. Prasad GA, Wu TT, Wigle DA, Buttar NS, Wongkeesong LM, Dunagan KT, Lutzke LS, Borkenhagen LS, Wang KK. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology. 2009 Sep; 137(3):815-23. Epub 2009 Jun 12. 1949879
    View PubMed
  23. Wang KK, Lutzke L, Borkenhagen L, Westra W, Song MW, Prasad G, Buttar NS. Photodynamic therapy for Barrett's esophagus: does light still have a role? Endoscopy. 2008 Dec; 40(12):1021-5. Epub 2008 Dec 08. 1915170
    View PubMed
  24. Prasad GA, Wang KK, Halling KC, Buttar NS, Wongkeesong LM, Zinsmeister AR, Brankley SM, Westra WM, Lutzke LS, Borkenhagen LS, Dunagan K. Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus. Cancer. 2008 Aug 1; 113(3):470-6. 1898715
    View PubMed
  25. Prasad GA, Wang KK, Halling KC, Buttar NS, Wongkeesong LM, Zinsmeister AR, Brankley SM, Fritcher EG, Westra WM, Krishnadath KK, Lutzke LS, Borkenhagen LS. Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus. Gastroenterology. 2008 Aug; 135(2):370-9. Epub 2008 May 07. 1966458
    View PubMed
  26. Yen CJ, Izzo JG, Lee DF, Guha S, Wei Y, Wu TT, Chen CT, Kuo HP, Hsu JM, Sun HL, Chou CK, Buttar NS, Wang KK, Huang P, Ajani J, Hung MC. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res. 2008 Apr 15; 68(8):2632-40. 1904831
    View PubMed
  27. Ilyas S, Demars CJ, Buttar NS. Chemoprevention in Barrett's Esophagus. Int J Gastrointest Cancer. 2008 Jan 03. [Epub ahead of print] 1926153
    View PubMed
  28. Milano F, Rygiel AM, Buttar N, Bergman JJ, Sondermeijer C, van Baal JW, ten Brinke A, Kapsenberg M, van Ham SM, Peppelenbosch MP, Krishnadath KK. An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer. Cancer Immunol Immunother. 2007 Dec; 56(12):1967-77. Epub 2007 Jun 13. 1844633
    View PubMed
  29. Song S, Guha S, Liu K, Buttar NS, Bresalier RS. COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2007 Nov; 56(11):1512-21. Epub 2007 Jun 29. 1846388
    View PubMed
  30. Prasad GA, Buttar NS, Wongkeesong LM, Lewis JT, Sanderson SO, Lutzke LS, Borkenhagen LS, Wang KK. Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus. Am J Gastroenterol. 2007 Nov; 102(11):2380-6. Epub 2007 Jul 19. 1849009
    View PubMed
  31. Prasad GA, Wang KK, Baron TH, Buttar NS, Wongkeesong LM, Roberts LR, LeRoy AJ, Lutzke LS, Borkenhagen LS. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma. Clin Gastroenterol Hepatol. 2007 Jun; 5(6):743-8. 1824710
    View PubMed
  32. Milano F, van Baal JW, Buttar NS, Rygiel AM, de Kort F, DeMars CJ, Rosmolen WD, Bergman JJ, VAn Marle J, Wang KK, Peppelenbosch MP, Krishnadath KK. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology. 2007 Jun; 132(7):2412-21. Epub 2007 Mar 19. 1830915
    View PubMed
  33. Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Krishnadath KK, Nichols FC 3rd, Lutzke LS, Borkenhagen LS. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2007 Apr; 132(4):1226-33. Epub 2007 Feb 07. 1818727
    View PubMed
  34. Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Lutzke LS, Borkenhagen LS. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc. 2007 Jan; 65(1):60-6. 1802274
    View PubMed
  35. Ilyas S, DeMars CJ, Buttar NS. Chemoprevention in Barrett's esophagus. J Gastrointest Cancer. 2007; 38(1):1-9. 1925881
    View PubMed
  36. Buttar NS, Fernandez-Zapico ME, Urrutia R. Key role of Kruppel-like factor proteins in pancreatic cancer and other gastrointestinal neoplasias. Curr Opin Gastroenterol. 2006 Sep; 22(5):505-11. 1779692
    View PubMed
  37. Prasad GA, Wang KK, Lutzke LS, Lewis JT, Sanderson SO, Buttar NS, Wong Kee Song LM, Borkenhagen LS, Burgart LJ. Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett's esophagus. Clin Gastroenterol Hepatol. 2006 Feb; 4(2):173-8. 1920700
    View PubMed
  38. Buttar NS, Wiersema MJ, Wang KK, DeMars CJ, Prasad GA, Lutzke LS. Rodent endosonography to monitor esophageal cancer. Int J Gastrointest Cancer. 2006; 37(2-3):84-90. 1971821
    View PubMed
  39. Maple JT, Petersen BT, Baron TH, Gostout CJ, Wong Kee Song LM, Buttar NS. Direct percutaneous endoscopic jejunostomy: Outcomes in 307 consecutive attempts. Am J Gastroenterol. 2005 Dec; 100(12):2681-8. 1737093
    View PubMed
  40. Wang KK, Wongkeesong M, Buttar NS. American Gastroenterological Association medical position statement: Role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology. 2005 May; 128(5):1468-70. 1716356
    View PubMed
  41. Wang KK, Wongkeesong M, Buttar NS. American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology. 2005 May; 128(5):1471-505. 1716357
    View PubMed
  42. Buttar NS, Wang KK. Mechanisms of disease: Carcinogenesis in Barrett's esophagus. Nature Clinical Practice Gastroenterology & Hepatology. 2004 Dec; 1(2):106-12. 1739891
    View PubMed
  43. Pacifico RJ, Wang KK, Wongkeesong LM, Buttar NS, Lutzke LS. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol. 2003 Jul; 1(4):252-7. 1646993
    View PubMed
  44. Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology. 2002 Apr; 122(4):1101-12. 1315394
    View PubMed
  45. Buttar NS, Wang KK, Anderson MA, Dierkhising RA, Pacifico RJ, Krishnadath KK, Lutzke LS. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study. J Natl Cancer Inst. 2002 Mar 20; 94(6):422-9. 1120932
    View PubMed
  46. Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc. 2001 Dec; 54(6):682-8. 1006826
    View PubMed
  47. Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, Anderson MA, Petterson TM, Burgart LJ. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001 Jun; 120(7):1630-9. 1005137
    View PubMed
  48. Kendrick ML, Buttar NS, Anderson MA, Lutzke LS, Peia D, Wang KK, Sarr MG. Contribution of intraoperative enteroscopy in the management of obscure gastrointestinal bleeding. J Gastrointest Surg. 2001 Mar-Apr; 5(2):162-7. 1003989
    View PubMed
  49. Buttar NS, Falk GW. Pathogenesis of gastroesophageal reflux and Barrett esophagus. Mayo Clin Proc. 2001 Feb; 76(2):226-34. 1003737
    View PubMed
  50. Buttar NS, Wang KK. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors. Mayo Clin Proc. 2000 Oct; 75(10):1027-38. 1012631
    View PubMed
  51. Krishnadath KK, Wang KK, Taniguchi K, Sebo TJ, Buttar NS, Anderson MA, Lutzke LS, Liu W. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology. 2000 Sep; 119(3):624-30. 137177
    View PubMed